Go Pro

This company has been marked as potentially delisted and may not be actively trading.

Galera Therapeutics (GRTX) News Today

Galera Therapeutics logo

Galera Therapeutics Latest News

Galera Therapeutics Inc.
Galera Therapeutics Sells Assets to Biossil Inc.
GRTX Galera Therapeutics, Inc. - Seeking Alpha
Galera Therapeutics extends agreement deadline
Newron Pharmaceuticals S.p.A. (NP5.DE)
GRTX Galera Therapeutics, Inc.
Galera Therapeutics, Inc. Common Stock (GRTX)
GRTX Apr 2024 0.500 call
Galera Therapeutics, Inc. (GRTX)
Galera Therapeutics Inc (GRTX)
Galera Therapeutics: Q3 Earnings Insights
Galera Therapeutics's Earnings Outlook
US Stocks Fall; Pfizer Swings To Q3 Loss

Galera Therapeutics Media Mentions By Week

Galera Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GRTX
News Sentiment

0.00

0.75

Average
Healthcare
News Sentiment

Galera Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GRTX Articles
This Week

0

0

GRTX Articles
Average Week

Galera Therapeutics Trends on MarketBeat

This week vs. last week
Searches
1
Page Views
575
+16%
Get Galera Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Galera Therapeutics dated 8/3/2026.
From Our Partners